Global leaders must urgently prioritise and work to provide access to new long-acting HIV prevention -- and potentially ...
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, is forecasted to grow at a robust CAGR of ...
From the ongoing political and legal battles over NHI, to the far-reaching health impacts of political change in the United States, it is set to be another tumultuous year for healthcare in South ...
So far, the FDA has approved the drug only for people who already have HIV that’s resistant to other treatments. But its ...
It’s all the more tragic because HIV drugs can keep people from catching the virus, and prevent those living with the virus from passing it on. If everyone who needed these drugs could access them, ...
The Global Fund to fight AIDS, TB and Malaria and the US President’s Emergency Plan for AIDS Relief (PEPFAR) recently ...
GILD has performed well in the past six months, with new drug approvals, positive data readouts and strong quarterly results.
Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...
We came across a bullish thesis on Merck & Co., Inc. (MRK) on Disruptive analytics’ Substack by Magnus Ofstad. In this ...
Researchers at the Max Planck Institute of Biophysics and Heidelberg University have observed largely intact HIV-1 capsids as ...